Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression.
about
Delirium and high fever are associated with subacute motor deterioration in Parkinson disease: a nested case-control studyActivation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamineBaseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson DiseaseGlial-mediated inflammation underlying parkinsonism.Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice.Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies.Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?Microglial priming in neurodegenerative disease.Review of delirium in patients with Parkinson's disease.The degenerating substantia nigra as a susceptible region for gene transfer-mediated inflammation.Role of the IL-1 Pathway in Dopaminergic Neurodegeneration and Decreased Voluntary Movement.Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease.Parkinson's disease and systemic inflammation.Alteration of Cytokines Levels in the Striatum of Rats: Possible Participation in Vacuous Chewing Movements Induced by Antipsycotics.
P2860
Q33699840-B82B16DD-054B-4090-B68F-3D3E89B2E8C0Q34936413-5BF9854F-CACA-4D4F-AFA4-6831176B4E6FQ35755849-FF708150-A201-4AA1-81F7-FACE7F7AE3BCQ37287778-59D435AA-27F2-47E7-A022-C96AE400B8B5Q37642992-6C2261FD-9B51-46D4-95A3-6FE3927E7642Q37878282-DCDF5E19-5FFF-4A91-8B38-444871657A6FQ37962621-4ECFF32D-1924-44E4-BC10-8FEBC0D94376Q38103856-94C28697-480E-4BFB-AE7B-B20B16A308EBQ38196699-084B9983-9605-46BB-B8B4-EC62507B9D02Q38469040-82556371-319C-444D-85D2-BF32B74974B1Q39737653-CFDA6298-EC03-4F02-AB86-D04F893A4D57Q41010767-3B6A369B-D02C-4F29-9700-37E670A78867Q41917715-83DEEB43-72E9-4FF2-9AEA-8677A755ED59Q42651923-687C669A-63CC-4BB2-B6DB-C9253BB82363Q48711490-6C826E50-4B79-454A-8B38-48CDFF97608E
P2860
Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Nigral neurodegeneration trigg ...... d by systemic IL-1 expression.
@en
Nigral neurodegeneration trigg ...... d by systemic IL-1 expression.
@nl
type
label
Nigral neurodegeneration trigg ...... d by systemic IL-1 expression.
@en
Nigral neurodegeneration trigg ...... d by systemic IL-1 expression.
@nl
prefLabel
Nigral neurodegeneration trigg ...... d by systemic IL-1 expression.
@en
Nigral neurodegeneration trigg ...... d by systemic IL-1 expression.
@nl
P1476
Nigral neurodegeneration trigg ...... ed by systemic IL-1 expression
@en
P2093
Carina Cintia Ferrari
María Clara Pott Godoy
P356
10.1016/J.JNEUROIM.2010.02.018
P577
2010-03-29T00:00:00Z